How Evox Therapeutics is targeting CNS diseases with exosomes
Our guest today is Dr. Per Lundin, CEO of Evox Therapeutics, a UK biotech using engineered exosomes to deliver genetic medicines directly into the brain.
Our guest today is Dr. Per Lundin, CEO of Evox Therapeutics, a UK biotech using engineered exosomes to deliver genetic medicines directly into the brain.